| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.05 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.08 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0006 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
| mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.05 |
| mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |